Iso TS 11135 2 2008
Iso TS 11135 2 2008
Iso TS 11135 2 2008
SPECIFICATION 11135-2
First edition
2008-08-01
Reference number
ISO/TS 11135-2:2008(E)
© ISO 2008
ISO/TS 11135-2:2008(E)
PDF disclaimer
This PDF file may contain embedded typefaces. In accordance with Adobe's licensing policy, this file may be printed or viewed but
shall not be edited unless the typefaces which are embedded are licensed to and installed on the computer performing the editing. In
downloading this file, parties accept therein the responsibility of not infringing Adobe's licensing policy. The ISO Central Secretariat
accepts no liability in this area.
Adobe is a trademark of Adobe Systems Incorporated.
Details of the software products used to create this PDF file can be found in the General Info relative to the file; the PDF-creation
parameters were optimized for printing. Every care has been taken to ensure that the file is suitable for use by ISO member bodies. In
the unlikely event that a problem relating to it is found, please inform the Central Secretariat at the address given below.
Contents Page
Foreword............................................................................................................................................................ iv
Introduction ........................................................................................................................................................ v
1 Scope ..................................................................................................................................................... 1
2 Normative references ........................................................................................................................... 1
3 Terms and definitions........................................................................................................................... 2
4 Quality management systems ............................................................................................................. 2
4.1 Documentation...................................................................................................................................... 2
4.2 Management responsibility ................................................................................................................. 2
4.3 Product realization................................................................................................................................ 3
4.4 Measurement, analysis and improvement — Control of non-conforming product ....................... 3
5 Sterilizing agent characterization ....................................................................................................... 3
5.1 Sterilizing agent .................................................................................................................................... 3
5.2 Microbicidal effectiveness ................................................................................................................... 3
5.3 Materials effects.................................................................................................................................... 3
5.4 Environmental considerations ............................................................................................................ 3
6
iTeh STANDARD PREVIEW
Process and equipment characterization .......................................................................................... 4
6.1 Process characterization ..................................................................................................................... 4
6.2
(standards.iteh.ai)
Equipment characterization................................................................................................................. 4
7 Product definition .................................................................................................................................
ISO/TS 11135-2:2008 5
7.1 General...................................................................................................................................................
https://standards.iteh.ai/catalog/standards/sist/7e9d2fcd-1e19-4496-92e2- 5
7.2 Product safety and performance.........................................................................................................
3149667922af/iso-ts-11135-2-2008 8
7.3 Microbiological quality ......................................................................................................................... 9
7.4 Documentation...................................................................................................................................... 9
8 Process definition................................................................................................................................. 9
9 Validation ............................................................................................................................................. 12
9.1 Installation qualification..................................................................................................................... 13
9.2 Operational qualification.................................................................................................................... 14
9.3 Performance qualification.................................................................................................................. 15
9.4 Varying load configurations .............................................................................................................. 19
9.5 Review and approval of validation.................................................................................................... 19
10 Routine monitoring and control ........................................................................................................ 20
10.1 General................................................................................................................................................. 20
10.2 Parametric release .............................................................................................................................. 21
11 Product release from sterilization..................................................................................................... 22
12 Maintaining process effectiveness ................................................................................................... 23
12.1 General................................................................................................................................................. 23
12.2 Maintenance of equipment ................................................................................................................ 23
12.3 Requalification .................................................................................................................................... 24
12.4 Assessment of change....................................................................................................................... 25
Annex A (informative) Guidance on ISO 11135-1:2007 Annex A Determination of process
lethality — Biological indicator/bioburden approach ..................................................................... 26
Annex B (informative) Guidance on ISO 11135-1:2007 Annex B Conservative determination of
lethal rate of the sterilization process — Overkill approach .......................................................... 36
Bibliography ..................................................................................................................................................... 38
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards bodies
(ISO member bodies). The work of preparing International Standards is normally carried out through ISO
technical committees. Each member body interested in a subject for which a technical committee has been
established has the right to be represented on that committee. International organizations, governmental and
non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the
International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
International Standards are drafted in accordance with the rules given in the ISO/IEC Directives, Part 2.
The main task of technical committees is to prepare International Standards. Draft International Standards
adopted by the technical committees are circulated to the member bodies for voting. Publication as an
International Standard requires approval by at least 75 % of the member bodies casting a vote.
In other circumstances, particularly when there is an urgent market requirement for such documents, a
technical committee may decide to publish other types of document:
⎯ an ISO Publicly Available Specification (ISO/PAS) represents an agreement between technical experts in
an ISO working group and is accepted for publication if it is approved by more than 50 % of the members
of the parent committee casting a vote;
iTeh STANDARD PREVIEW
⎯ (standards.iteh.ai)
an ISO Technical Specification (ISO/TS) represents an agreement between the members of a technical
committee and is accepted for publication if it is approved by 2/3 of the members of the committee casting
a vote.
ISO/TS 11135-2:2008
https://standards.iteh.ai/catalog/standards/sist/7e9d2fcd-1e19-4496-92e2-
An ISO/PAS or ISO/TS is reviewed after three years in order to decide whether it will be confirmed for a
3149667922af/iso-ts-11135-2-2008
further three years, revised to become an International Standard, or withdrawn. If the ISO/PAS or ISO/TS is
confirmed, it is reviewed again after a further three years, at which time it must either be transformed into an
International Standard or be withdrawn.
Attention is drawn to the possibility that some of the elements of this document may be the subject of patent
rights. ISO shall not be held responsible for identifying any or all such patent rights.
ISO/TS 11135-2 was prepared by Technical Committee ISO/TC 198, Sterilization of health care products.
ISO/TS 11135-2, together with ISO 11135-1, cancels and replaces ISO 11135:1994 and
ISO 11135/Cor.1:1994, which have been technically revised.
ISO/TS 11135 consists of the following parts, under the general title Sterilization of health care products —
Ethylene oxide:
⎯ Part 1: Requirements for development, validation and routine control of a sterilization process for medical
devices
Introduction
This Technical Specification describes some of the methods that may be employed to achieve the
requirements contained in ISO 11135-1. This document is not intended as a checklist for assessing
compliance with ISO 11135-1, rather it is intended to promote a uniform understanding and implementation of
ISO 11135-1 by providing explanations and possible methods for achieving compliance with specified
requirements. It highlights important aspects and provides examples.
This Technical Specification addresses ethylene oxide (EO) sterilization in both the industrial and health care
facility settings, and it acknowledges the similarities and differences between the two applications.
Among the similarities are the common need for quality systems, staff training, and proper safety measures.
The major differences relate to the unique physical and organizational conditions in health care facilities, and
to the initial condition of re-usable devices being presented for sterilization.
Health care facilities differ from medical device manufacturers in the physical design of processing areas, in
the equipment used, and in the availability of personnel with adequate levels of training and experience. The
primary function of the health care facility is to provide patient care; medical device reprocessing is just one of
a myriad of activities that are performed to support that function.
In terms of the initial condition of medical devices, medical device manufacturers generally sterilize large
iTeh STANDARD PREVIEW
numbers of similar devices that have been produced from virgin material. Health care facilities, on the other
hand, must handle and process both new medical devices and re-usable medical devices of different
(standards.iteh.ai)
descriptions and with varying levels of bioburden. They are therefore faced with the additional challenges of
cleaning, evaluating, preparing and packaging a medical device prior to sterilization. In this document,
ISO/TS
alternative approaches and guidance specific 11135-2:2008
to health care facilities are identified as such.
https://standards.iteh.ai/catalog/standards/sist/7e9d2fcd-1e19-4496-92e2-
In general, moist heat sterilization 3149667922af/iso-ts-11135-2-2008
(also known as steam sterilization) is the method of choice for medical
devices and supplies that are sterilized in health care facilities. However, EO gas and its mixtures are effective
sterilants that are primarily used for heat- and moisture-sensitive medical devices that cannot be steam
sterilized.
For ease of reference, the numbering in this technical specification corresponds to that in ISO 11135-1.
1 Scope
This Technical Specification provides guidance for the requirements in ISO 11135-1:2007. It does not repeat
the requirements and is not intended to be used in isolation.
For ease of reference, the clause numbering in this Technical Specification corresponds to that in
ISO 11135-1:2007. Further guidance for the requirements given in ISO 11135-1 is also included in Annex C of
ISO 11135-1:2007 and should be used in conjunction with this Technical Specification.
ISO/TS 11135-2:2008
2 https://standards.iteh.ai/catalog/standards/sist/7e9d2fcd-1e19-4496-92e2-
Normative references
3149667922af/iso-ts-11135-2-2008
The following referenced documents are indispensable for the application of this document. For dated
references, only the edition cited applies. For undated references, the latest edition of the referenced
document (including any amendments) applies.
ISO 11135-1:2007, Sterilization of health care products — Ethylene oxide — Part 1: Requirements for
development, validation and routine control of a sterilization process for medical devices
ISO 11138-2:2006, Sterilization of health care products — Biological indicators — Part 2: Biological indicators
for ethylene oxide sterilization processes
ISO 11140-1:2005, Sterilization of health care products — Chemical indicators — Part 1: General
requirements
ISO 13485:2003, Medical devices — Quality management systems — Requirements for regulatory purposes
ISO 17664, Sterilization of medical devices — Information to be provided by the manufacturer for the
processing of resterilizable medical devices
3.1
dunnage
material used to mimic all or part of a sterilization load
3.2
health care facility
set of physical infrastructure elements intended to support the delivery of specific health-related services
3.3
processing group
collection of products or product families that can be sterilized in the same EO sterilization process
NOTE All products within the group have been determined to present an equal or lesser challenge to the sterilization
process than the challenge device for that group.
3.4
EO product family
collection of products that are determined to be similar or equivalent for validation purposes
3.5
re-usable medical device
iTeh STANDARD PREVIEW
medical device designated or intended by the manufacturer as suitable for reprocessing and re-use
3.6
ISO/TS 11135-2:2008
single use medical device
https://standards.iteh.ai/catalog/standards/sist/7e9d2fcd-1e19-4496-92e2-
medical device that is designated or intended by the manufacturer for one-time use only
3149667922af/iso-ts-11135-2-2008
3.7
sterilization specialist
person with knowledge of the sterilization technology being utilized and its effects upon materials and
microorganisms
NOTE This level of knowledge has been obtained by both practical and theoretical means and the person does not
require guidance on the basic principles of the technology involved.
4.1 Documentation
4.2.1 Each organization should establish procedures for identifying training needs and ensure that all
personnel are trained to adequately perform their assigned responsibilities.
4.3.1 Purchasing procedures in a health care facility should ensure that re-usable medical devices are
supplied with validated instructions for cleaning, disinfection, sterilization and aeration as specified in
ISO 17664.
4.3.2 For those facilities that do not fully comply with ISO 13485, such as health care facilities, procedures
for identification of product and maintenance of traceability, should include the labelling of each item or
package prior to sterilization with a lot control identifier that includes the following information:
c) the cycle number (i.e. the cycle run of the day or sterilizer).
It is recommended that the identity of the person who assembled the pack also be included on the identifier, to
allow for further investigation if a problem should arise.
Lot identification information enables personnel to retrieve items in the event of a recall and to trace problems
to their source.
EO is a highly penetrative gas that will permeate most packaging materials and polymeric materials. Widely
recognized compositions include 100 % EO and blends with carbon dioxide or nitrogen. The storage
conditions for EO should be in accordance with the EO manufacturer’s recommendations and all applicable
regulations.
No guidance offered.
No guidance offered.
5.4.1 EO is toxic, flammable and explosive; therefore, extreme caution should be used during its storage,
handling and use.
5.4.2 Effluent gas should be discharged through an EO-gas treatment system, such as a catalytic oxidiser,
wet acid scrubber or thermal oxidiser.
When choosing a diluent, its ozone depleting potential should be taken into consideration.
No guidance offered.
6.2.1 The following factors should be considered when characterizing the equipment.
Preconditioning may be performed in a separate preconditioning area (chamber, cell or room). The
preconditioning area (if used) should have the following performance and monitoring capabilities:
⎯ air circulation system: adequate air circulation to ensure the uniformity of temperature and humidity in
the usable space, and to ensure that uniformity is maintained in a fully loaded room or chamber;
⎯ a time clock or other means of recording time of load entry into and removal from the preconditioning
area, if applicable.
The sterilization chamber should have the following performance and monitoring capabilities:
⎯ means of monitoring chamber pressure, temperature and humidity (if humidity additions are
controlled by sensor readings);
⎯ means of controlling chamber pressure, temperature and humidity, if humidity additions are
controlled by sensor readings [when sensors are fixed on the equipment, ensure that a correlation is
made during installation qualification (IQ) or operational qualification (OQ) at the coldest location];
⎯ if parametric release is used, instrumentation for the direct analysis of humidity during conditioning
and EO concentration during sterilant exposure time;
⎯ a system controlling that gaseous EO was admitted to the chamber. This can be done by measuring
the temperature of the EO gas flowing from the vaporizer to the sterilizer chamber or monitoring the
pressure rise during EO injection. This system may control EO concentration during sterilant
exposure time.
An aeration area (chamber, cell or room) may be used to remove EO residuals from product/packaging.
Temperature uniformity, fresh air make-up and air re-circulation throughout the area are important to ensure
consistent and reproducible results. The aeration area should have the following:
⎯ airflow detection equipment, alarm systems or indicators monitoring the air handling system to
ensure that it operates within specified parameters and maintains adequate airflow in a fully loaded
room or chamber;
Prior to removing product from a sterilizer, precautions should be taken to ensure that operators are not
exposed to high levels of EO due to the outgassing of the load.
The equipment specification should be reviewed to ensure that regulatory and safety requirements are met,
technical specifications are appropriate, and services and infrastructure necessary to operate the equipment
are available.
6.2.2 Humidification by steam injection is required in ISO 11135-1, because humidifiers that operate by
dispersion of unheated water as an aerosol (e.g. spinning disc humidifiers and nebulizers) can be potent
sources of microbial contamination.
b) use two sensors, or their average value, for both monitoring and control; this system needs to generate
an automatic fault condition if the difference between the two sensors exceeds a defined value;
c) use dual element sensors for both monitoring and control; this system needs to generate an automatic
fault condition if the difference between the two elements exceeds a defined value.
7 Product definition
7.1 General
Product definition involves documentation of essential information about the medical device to be sterilized (i.e.
the new or modified product).
7.1.1 Product definition for a medical device includes the medical device itself, the primary package
containing the device, and any accessories, instructions, or other items included in the primary package. It
also includes a description of the intended functionality of the medical device, and the available manufacturing
and sterilization processes. The product definition process should also consider whether this is a new design,
or whether it is part of an existing EO product family.
c) whether the medical device is intended for single use or for multiple use;
d) design characteristics that would affect the choice of sterilization process (e.g. batteries, fibre-optics,
computer chips);
e) raw materials/manufacturing conditions that could affect microbiological quality (e.g. materials of natural
origin);
g) packaging;
h) loading pattern; requirements for a specific load or mixed loading patterns, or range of acceptable loading
patterns;
i) compatibility with the sterilant gas or gas mixture and EO processing conditions (preconditioning,
sterilization and aeration processes).
7.1.2 A technical review should be performed to compare the new or modified product to the validated
product and/or process challenge device (PCD) that was used to validate the existing EO process. The
construction and configuration of the new or modified product should be carefully examined for any features
that could present obstacles to the penetration of EO, heat or humidity. For medical device manufacturers, this
comparison should also involve an examination of factors that could affect the initial bioburden on the product,
including the location of the manufacturing facilities, the types of raw material used, the sources of these
materials and production methods. For new re-usable products, this comparison should include the evaluation
iTeh STANDARD PREVIEW
of the cleaning efficacy for this product.
As part of the technical review the following questions should be considered. If the answer to any of the
following questions is “yes,” further evaluation of the new or modified product might be necessary to determine
if it is more difficult to sterilize than the previously validated product:
a) With respect to the previously validated product, does the new or modified product:
7) include changes or differences that could reduce the transfer of heat, moisture or sterilant gas;
8) have a bioburden number or resistance significantly higher than that of the reference product (due to
manufacturing conditions, handling, cleaning process or materials used) or
9) contain materials or structures that could be adversely affected by the proposed processing or
sterilization method?
b) With respect to the previously validated product, does the packaging of the new or modified product:
2) have any additional impermeable protective barriers, e.g. container, case, template, that would
restrict or interfere with sterilant or humidity penetration or removal;
3) have a change in the porosity of the packaging material (e.g. basis weight, coating, treatment –
adhesive or coating on paper);
4) have a decrease in the surface area of the venting material or underlying opening, e.g. application of
tape or secondary label, change in size of label;
c) With respect to the previously validated product, does the load configuration of the new or modified
product:
1) differ significantly from the validated load configuration of the reference load;
4)
iTeh STANDARD PREVIEW
differ significantly in total load volume?
(standards.iteh.ai)
7.1.3 No guidance offered.
ISO/TS 11135-2:2008
7.1.4 No guidancehttps://standards.iteh.ai/catalog/standards/sist/7e9d2fcd-1e19-4496-92e2-
offered.
3149667922af/iso-ts-11135-2-2008
7.1.5 A means of demonstrating equivalence is the comparison of the relative rates of inactivation of BIs
placed in the most difficult-to-sterilize location within the new or modified product and previously validated
product when both are exposed to a fractional cycle.
A PCD is a device or test pack into which a microbiological challenge is located. Examples of ways to develop
PCDs for use in the demonstration of equivalence include, but are not limited to:
a) placement of a microbiological challenge between rings, lands, grommets or ribs of a syringe stopper;
b) placement of a microbiological challenge in the middle of the lumen of a tube that is then reconnected
using a solvent bond agent or a connector to restore product integrity;
Several PCD designs have been recommended for use in health care facilities.
NOTE 1 For further information see EN 1422[13], ANSI/AAMI ST41[11] and AS/NZS 4187[12].
To prepare the PCD, the microbiological challenge can be inoculated on the product either directly or indirectly.
Direct inoculation is accomplished by applying a liquid suspension of the spores on the product. Indirect
inoculation is accomplished by placing an inoculated carrier either within the package or in/on the product.